TEXT GOAICR TO 74121
Phase II through IV dermatology studies
randomized patients
dermatological indications including eczema, psoriasis and acne
About us
Since 2013, we have worked diligently to build our reputation in the dermatology community as a site that gives meticulous attention to detail, dedicated patient care and excellent data capture. As the largest multisite research organization and private dermatology practice in the United States, we offer the following benefits:
Simplified logistics via a dedicated, centralized team overseeing all trial locations
Dedicated research personnel at each location
Unmatched access to a pool of potential trial participants
Accessible board-certified dermatologist principal investigators and sub investigators
AICR
- 200-plus Phase II through IV dermatology studies
- Over 4,000 randomized patients
- 26 dermatological indications including eczema, psoriasis and acne
- Four principal investigators and eight sub investigators
- 10-plus device studies that are on the cutting-edge of dermatological treatment
Sanova
- 11 locations in two states
- Total patient population of 50,000
- 30 providers
- 10 research principal investigators and several sub investigators
“Exemplary site with a PI and skilled study staff that’s consistently responsive to CRO/Sponsor request. A pleasure to work with!”
Our team
Edward (Ted) Lain, M.D.
Board-certified dermatologist
Executive Director of AICR
Principal investigator
Pflugerville
Megan Couvillion, M.D.
Board-certified dermatologist
Principal investigator
Houston
Sub investigator
Houston
Helyn Alvarez, M.D.
Board-certified dermatologist
Sub investigator
Houston
Jennifer Jordan, PA-C
Sub investigator
Pflugerville
Marcela Ramirez, MSN FNP-C, Nurse Practitioner
Sub investigator
Houston
